OST submitted regulatory updates to the FDA and held a conference in Utah.
1 report, 0 independent
Updated Jun 30
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
OST submitted regulatory updates to the FDA and held a conference in Utah.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Related events
- FDA announced regulatory clearance in Salt Lake City on September 25, 2026.
- A study protocol involving a company based in Mont-Saint-Guibert was approved by the U.S. FDA.
- A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.
- Jazz Pharmaceuticals received FDA approval for a drug following positive clinical trial results.
- Future sales of a product are contingent upon obtaining the necessary FDA registration and labeling, while the state simultaneously announces actions to remove regulatory barriers.
Coverage
Newest first; wire copies grouped- Unknown outlet